Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Giuseppe Fragale
Observed names:
FRAGALE, GIUSEPPE,
G. Fragale
Institution:
IFOM
Observed institutions:
IFOM,
University of Turin
ORCID:
0000-0003-0081-8059
Observed ORCID:
0000-0003-0081-8059
OpenAlex ID:
A5083383348
Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects
2022
·
Salvatore Cortellino
, Alessandro Raveane
, et al.
·
Cell Reports
·
76
PDF
Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity
2021
·
Laura Seclì
, Lidia Avalle
, et al.
·
Cancer Research
·
39
PDF
Clonal cooperation through soluble metabolite exchange facilitates metastatic outgrowth by modulating Allee effect
2023
·
Benjamin J. Hershey
, Sara Barozzi
, et al.
·
Science Advances
·
20
PDF
Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
·
Cancer Research
·
14
PDF
Compressive stress couples calcium signalling to translational control and proteostasis
2026
·
Giuseppe Fragale
, Benjamin J. Hershey
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Supplementary Data from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure7 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure6 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
Data from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
STable 1 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure2 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure5 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure1 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure5 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure4 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure7 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure6 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure4 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure3 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
SFigure1 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024
·
Franca Raucci
, Claudio Vernieri
, et al.
Data from Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity
2023
·
Laura Seclì
, Lidia Avalle
, et al.
Supplementary Data from Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity
2023
·
Laura Seclì
, Lidia Avalle
, et al.
PDF
Supplementary Data from Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity
2023
·
Laura Seclì
, Lidia Avalle
, et al.
PDF
Supplementary Data from Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity
2023
·
Laura Seclì
, Lidia Avalle
, et al.
Data from Targeting the Extracellular HSP90 Co-Chaperone Morgana Inhibits Cancer Cell Migration and Promotes Anticancer Immunity
2023
·
Laura Seclì
, Lidia Avalle
, et al.
Show more works
View as search
Works count:
27
Citation count:
149
H-index:
4
I10-index:
4
Year
Topic
Type
